Berman Capital Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	$3K	Sell	64 -49	-43%	-$2.3K	﹤0.01%	1575
2021 Q2	$4K	Buy	113 +29	+35%	+$1.03K	﹤0.01%	1396
2021 Q1	$4K	Buy	84 +32	+62%	+$1.52K	﹤0.01%	1326
2020 Q4	$2K	Sell	52 -89	-63%	-$3.42K	﹤0.01%	1395
2020 Q3	$6K	Buy	+141	New	+$6K	﹤0.01%	960